Targeted drug delivery utilizing protein-like molecular architecture.
about
Use of Targeted Liposome-based Chemotherapeutics to Treat Breast CancerNanocarriers for diagnosis and targeting of breast cancerChondroitin Sulfate as a Molecular Portal That Preferentially Mediates the Apoptotic Killing of Tumor Cells by Penetratin-directed Mitochondria-disrupting PeptidesArchitectonics of phage-liposome nanowebs as optimized photosensitizer vehicles for photodynamic cancer therapy.The benefits and challenges associated with the use of drug delivery systems in cancer therapyDelivery of intact transcription factor by using self-assembled supramolecular nanoparticles.Extracellular proteases as targets for drug developmentApplication of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems.Liposomal Doxorubicin in the treatment of breast cancer patients: a reviewAnticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.The treatment of breast cancer using liposome technology.Cell penetrating peptide amphiphile integrated liposomal systems for enhanced delivery of anticancer drugs to tumor cells.A liposome-based nanostructure for aptamer directed delivery.ECM turnover-stimulated gene delivery through collagen-mimetic peptide-plasmid integration in collagen.[Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction.Characterization and pharmacokinetics of a novel pirarubicin liposome powder.Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9.Microwave-assisted synthesis of triple-helical, collagen-mimetic lipopeptides.Molecular simulations of peptide amphiphiles.Targeted Delivery of Protein Drugs by Nanocarriers.Preparation of a gel-coated liposome and its application in drug releaseTunable wavelength light emission and amplification in Rhodamine 6G aggregates
P2860
Q26797230-C579EDAA-462C-4CB7-B04B-BD74434A9821Q26862309-C58DC7AC-6773-402B-965E-C9DC19634222Q28397647-F9CAA105-01E4-4922-A860-12E8317EA042Q33679580-D9CB814E-3302-4707-AA90-5F3BC7215925Q33965271-B39240BD-68D6-4F8D-9F18-7C79A5ACE74DQ34932130-2E5F14B2-7B47-47CF-949E-3F388EC15BFAQ35116202-8B7F5C30-E924-47E3-B8A5-5AB5951D88DDQ36421268-29278FB2-1F8B-4738-ACFC-742A9A334762Q36748268-F7CAEA6C-F5EE-4396-AE8B-3E00497BC15EQ37188974-380883E6-D0B5-4392-BF09-9328939502E4Q37268062-5B4DD6C7-C29F-4682-B792-54CA53525F77Q37572760-0DF218FD-FFCC-4036-BCEF-F5EBC384D4D6Q38002854-720E2CA0-BA90-41C6-AE56-387939E5BD98Q39219757-040E20C8-1CCA-4860-8938-F75C794EAE62Q39760965-E8651224-872E-4B35-8CDD-50236405055BQ40060384-BF53187E-31E2-49CA-9B0C-D3ECBC91D820Q41383344-37030FCE-1691-4321-9E04-39D1819AA0FFQ43048923-0824E329-57A3-4BA5-8C1C-7A1C30090E23Q43179077-B46876E4-E947-4459-AF95-17E4FC8330EAQ43199678-7350A807-05BE-448A-9F22-9275D05C0DB8Q50275649-644D3F50-DFFF-4102-B38B-5BD92EAF5BD4Q54647504-CDABE3F9-A8F5-4745-8C52-E2BAEF5BC782Q57342708-D006ADAA-0DFF-42AC-96DF-40AFAC837E86Q58187079-006097F8-72AE-4ED2-9A26-ED7A75D84C1D
P2860
Targeted drug delivery utilizing protein-like molecular architecture.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Targeted drug delivery utilizing protein-like molecular architecture.
@en
type
label
Targeted drug delivery utilizing protein-like molecular architecture.
@en
prefLabel
Targeted drug delivery utilizing protein-like molecular architecture.
@en
P2093
P2860
P356
P1476
Targeted drug delivery utilizing protein-like molecular architecture.
@en
P2093
David R Khan
Diane Baronas-Lowell
Evonne M Rezler
Gregg B Fields
Janelle Lauer-Fields
Mare Cudic
P2860
P304
P356
10.1021/JA066929M
P407
P577
2007-03-31T00:00:00Z